Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 2 recruiting now early-phase tilt small index

Atopic Dermatitis Eczema: early-phase trial registry

2 of 9 indexed Atopic Dermatitis Eczema trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,916 of 28,707 conditions by registered trial count.

9 US clinical trials · 2 currently recruiting · #1,916 of 28,707 conditions by registered trial count

Atopic Dermatitis Eczema: 9 US clinical trials tracked, 2 recruiting.

Atopic Dermatitis Eczema is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is ClinOhio Research Services, running 1 of these trials.

Enrollment posture brief

Registry condition atopic-dermatitis-eczema

OPEN 2 | RECR 22% | LATE 0 | EARLY 5 | RANK #1916 | SPON 1

Nearest open-share peer: Acne (22% recruiting · 27 trials)

Acute Lymphoblastic Leukemia55.6%Acute Respiratory Distress S55.6%Acute Otitis Media22.2%Atopic Dermatitis Eczema (th…22%Acute Heart Failure11.1%
Open-enrollment share among volume-matched conditions near Atopic Dermatitis Eczema

Atopic Dermatitis Eczema lists 2 open slots (22% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Atopic Dermatitis Eczema on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Atopic Dermatitis Eczema is recruiting below its size-band peers.

    2 of 9 indexed trials (22.2%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Atopic Dermatitis Eczema trials is spread across many organizations.

    ClinOhio Research Services accounts for 1 of 9 trials (11.1%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical Atopic Dermatitis Eczema enrolment sits around 210 participants.

    Median target enrolment is 210 among the 9 trials that report a genuine target (sentinel values excluded). 3 of those (33.3%) plan for fewer than 100 participants.

  4. Atopic Dermatitis Eczema research is mostly interventional.

    8 interventional and 1 observational studies make up this index (88.9% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 24

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 4

Named interventions

Most-linked intervention names on Atopic Dermatitis Eczema records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Other
2 trials
Placebo Drug
2 trials
AO+Mist Other
1 trials
Arctiva Other
1 trials
Autologous Microbial Transplant Biological
1 trials
Team-Based Connected Health (TCH) Other
1 trials
HY209GEL Active Drug
1 trials
Fluticasone propionate Cream 0.05% Combination
1 trials

US sites by state

Facility locations filed on Atopic Dermatitis Eczema trials. A trial with sites in several states counts in each.

California 6 trials
Ohio 3 trials
Illinois 3 trials
Pennsylvania 2 trials
New York 2 trials
Washington 1 trials
Texas 1 trials
South Carolina 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Atopic Dermatitis Eczema page

9 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Atopic Dermatitis Eczema condition card totals 9 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.